Article Details
Retrieved on: 2022-07-02 22:54:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Evusheld, developed by AstraZeneca, was approved by drug regulators in March after a study showed it reduced the chances of Covid infections by 80 ...
Article found on: www.dailymail.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here